Vistaril label

Vistaril

Vistaril Recall

Get an alert when a recall is issued.

Add Info

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Add Info

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Add Info

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

Add Info

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.

Add Info

Uses

The total management of anxiety, tension, and psychomotor agitation in conditions of emotional stress requires in most instances a combined approach of psychotherapy and chemotherapy. Hydroxyzine has been found to be particularly useful for this latter phase of therapy in its ability to render the disturbed patient more amenable to psychotherapy in long term treatment of the psychoneurotic and psychotic, although it should not be used as the sole treatment of psychosis or of clearly demonstrated cases of depression.

Hydroxyzine is also useful in alleviating the manifestations of anxiety and tension as in the preparation for dental procedures and in acute emotional problems. It has also been recommended for the management of anxiety associated with organic disturbances and as adjunctive therapy in alcoholism and allergic conditions with strong emotional overlay, such as in asthma, chronic urticaria, and pruritus.

VISTARIL (hydroxyzine hydrochloride) Intramuscular Solution is useful in treating the following types of patients when intramuscular administration is indicated:

  1. The acutely disturbed or hysterical patient.
  2. The acute or chronic alcoholic with anxiety withdrawal symptoms or delirium tremens.
  3. As pre- and postoperative and pre- and postpartum adjunctive medication to permit reduction in narcotic dosage, allay anxiety and control emesis.

VISTARIL (hydroxyzine hydrochloride) has also demonstrated effectiveness in controlling nausea and vomiting, excluding nausea and vomiting of pregnancy. (See Contraindications.)

In prepartum states, the reduction in narcotic requirement effected by hydroxyzine is of particular benefit to both mother and neonate.

Hydroxyzine benefits the cardiac patient by its ability to allay the associated anxiety and apprehension attendant to certain types of heart disease. Hydroxyzine is not known to interfere with the action of digitalis in any way and may be used concurrently with this agent.

The effectiveness of hydroxyzine in long term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should reassess periodically the usefulness of the drug for the individual patient.

Add Info

History

There is currently no drug history available for this drug.

Add Info

Other Information

There are no additional details available for this product.

Add Info
Add to My Alerts
Report Side Effect
Leave a Review
Navigate to :
Vistaril Recall
Side Effects & Adverse Reactions
Legal Issues
FDA Safety Alerts
Manufacturer Warnings
FDA Labeling Changes
Uses
History
Other Information
Manufacturers
Trending Topics

Vistaril Manufacturers

  • Roerig
    Vistaril | Roerig
    No Recall

    Vistaril | Roerig

    Vistaril | Roerig

    The recommended dosages for VISTARIL (hydroxyzine hydrochloride) Intramuscular Solution are:

    For adult psychiatric and emotional emergencies, including acute alcoholism. IM: 50–100 mg stat., and q. 4–6h., p.r.n. Nausea and vomiting excluding nausea and vomiting of pregnancy. Adults: 25–100 mg IM Children: 0.5 mg/lb body weight IM Pre- and postoperative adjunctive medication. Adults: 25–100 mg IM Children: 0.5 mg/lb body weight IM Pre- and postpartum adjunctive therapy. 25–100 mg IM

    As with all potent medications, the dosage should be adjusted according to the patient's response to therapy.

    FOR ADDITIONAL INFORMATION OF THE ADMINISTRATION AND SITE OF SELECTION SEE PRECAUTIONS SECTION. NOTE: VISTARIL (hydroxyzine hydrochloride) Intramuscular Solution may be administered without further dilution.

    Patients may be started on intramuscular therapy when indicated. They should be maintained on oral therapy whenever this route is practicable.

  • Remedyrepack Inc.
    Vistaril | Remedyrepack Inc.
    No Recall

    Vistaril | Remedyrepack Inc.

    Vistaril | Remedyrepack Inc.

    For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested: in adults, 50–100 mg q.i.d.; children under 6 years, 50 mg daily in divided doses; and over 6 years, 50–100 mg daily in divided doses.

    For use in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus: in adults, 25 mg t.i.d. or q.i.d.; children under 6 years, 50 mg daily in divided doses; and over 6 years, 50–100 mg daily in divided doses.

    As a sedative when used as a premedication and following general anesthesia: 50–100 mg in adults, and 0.6 mg/kg in children.

    When treatment is initiated by the intramuscular route of administration, subsequent doses may be administered orally.

    As with all medications, the dosage should be adjusted according to the patient's response to therapy.

     

  • Pfizer Laboratories Div Pfizer Inc
    Vistaril | Pfizer Laboratories Div Pfizer Inc
    No Recall

    Vistaril | Pfizer Laboratories Div Pfizer Inc

    Vistaril | Pfizer Laboratories Div Pfizer Inc

    For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested: in adults, 50–100 mg q.i.d.; children under 6 years, 50 mg daily in divided doses; and over 6 years, 50–100 mg daily in divided doses.

    For use in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses, and in histamine-mediated pruritus: in adults, 25 mg t.i.d. or q.i.d.; children under 6 years, 50 mg daily in divided doses; and over 6 years, 50–100 mg daily in divided doses.

    As a sedative when used as a premedication and following general anesthesia: 50–100 mg in adults, and 0.6 mg/kg in children.

    When treatment is initiated by the intramuscular route of administration, subsequent doses may be administered orally.

    As with all medications, the dosage should be adjusted according to the patient's response to therapy.

Login To Your Free Account